Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. - Wikidata - awgldk - TriplyDB

Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.

Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.

http://www.wikidata.org/entity/Q34717418

about

Dopamine release in the basal ganglia Multiple roles for nicotine in Parkinson's disease In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration The neuronal nicotinic acetylcholine receptors alpha 4* and alpha 6* differentially modulate dopamine release in mouse striatal slices Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation Local control of striatal dopamine release Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals Molecules and circuits involved in nicotine addiction: The many faces of smoking Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype Characterization of a Novel -Conotoxin from Conus textile That Selectively Targets 6/ 3 2 3 Nicotinic Acetylcholine Receptors Mechanistic insights into nicotine withdrawal.Role of Nitric Oxide on Dopamine Release and Morphine-Dependency Dopaminergic and cholinergic learning mechanisms in nicotine addiction Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum Expression profile of nicotinic acetylcholine receptor subunits in the brain of HIV-1 transgenic rats given chronic nicotine treatment.Roles for N-terminal extracellular domains of nicotinic acetylcholine receptor (nAChR) β3 subunits in enhanced functional expression of mouse α6β2β3- and α6β4β3-nAChRs.Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease Replicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence.Nicotine withdrawal.Analysis of rare variations reveals roles of amino acid residues in the N-terminal extracellular domain of nicotinic acetylcholine receptor (nAChR) alpha6 subunit in the functional expression of human alpha6*-nAChRs.Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine.Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats.Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens.Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors.Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.The frequency-dependence of the nicotine-induced inhibition of dopamine is controlled by the α7 nicotinic receptor Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease Acute ethanol inhibits dopamine release in the nucleus accumbens via α6 nicotinic acetylcholine receptors Sex, ADHD symptoms, and smoking outcomes: an integrative model.Striatal dopamine transmission is subtly modified in human A53Tα-synuclein overexpressing mice.α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease

P2860

Q22251247-244EC856-605B-4C6E-89B6-19348AF25042 Q22252514-617E076D-B4DD-42C0-B2D6-A60DEC3ECE20 Q24643170-AE15F625-5A8B-4118-9A52-AC34142B210A Q24650892-80F995BB-5963-4F89-826F-1AC283340B04 Q24655429-8FD1BA26-72FC-441F-9DB7-FA4D5932CA94 Q26774830-DFF629D8-D855-4EBB-8CF9-9CD5AA1A19D4 Q26861838-93B6D10C-7A88-45A0-A76B-50E20310DF28 Q26861923-7979A7FC-758E-4920-9443-AEEBA7C4B1A3 Q27008063-09F95C07-6AFC-4DEA-928F-A11364E110E4 Q27021772-C945463F-138B-4F63-9AB8-4CDB60DA988D Q27675258-6E6B1158-5283-4BAC-8035-5C090DDEDB71 Q27687645-3FBA2B89-80FE-48D9-9088-833982CC8467 Q28068951-50865C2F-AEA8-40B2-B80E-C5DE2F4D9960 Q28084459-710D5825-95E0-4FDF-9157-CC55AA27C2D4 Q28388268-0C7998B1-9C3D-45F4-B5A1-68E5B9A76A30 Q28576280-115AA30D-8179-42E5-B061-6BD47C64FC18 Q30277012-B6BB1EA3-517D-4A0C-8366-7ADD55B1754B Q30370472-61E90275-E29D-4EB3-9B91-273899084A69 Q30383888-531C4BEC-1753-46C4-B6F1-7A2B402D7B2C Q30395065-F97389F4-8174-4511-8528-8F41BFDA0D5D Q30404700-B8497336-6845-4200-BA94-0A6F268784DC Q30413058-30048725-216B-4ACB-B8FF-4EEFF18E2AE1 Q30475334-C7501D77-52BE-440A-8FCE-70BDDEDCA5D1 Q30493138-004A06C1-CF0D-4BD8-9E03-A7C49C0096A7 Q30738165-30ABCD2F-0435-4B4F-A49D-284EA27A21F2 Q33621205-8D80674A-4079-4F21-9768-FA3E77A166FF Q33738559-31CE3A45-B349-4FF4-86FA-686D184CEDF6 Q33770793-3164029B-8442-488C-9E37-0E2CDCAC62A9 Q33835219-20F1EB0E-FCBC-4D61-908C-CE2801C38FB1 Q33870433-CDD6F10A-34F0-4168-9499-76058F25FEA8 Q33929766-078FC7C8-CC52-484B-B449-865790552F9E Q33954007-C7CB4558-3BE9-4B6E-A3A3-83FFCA097760 Q33955964-4EEB2AD4-D414-44FE-B239-917D44BEBF30 Q34125225-B90CDEDF-8319-49C3-B931-C3E763848EFB Q34154675-32D694A3-BFD1-4B6D-A313-6896A1C43863 Q34181259-FB519868-5C97-43C2-B6AD-BA050D7E83CD Q34219378-FE11AE7F-75B2-4DC3-A62B-62DE5CF34DF1 Q34255025-9F840506-F559-4BD4-91CC-E83241F5999D Q34263294-3E1E70AF-2F1A-4E24-9350-0C9AB3EB7756 Q34309950-79BDF57C-AF25-4DBA-BB42-C32F266B0747

P2860

Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.

http://www.wikidata.org/entity/Q34717418

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.

@ast

Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.

@en

Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.

@nl

type

label

Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.

@ast

Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.

@en

Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.

@nl

prefLabel

Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.

@ast

Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.

@en

Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.

@nl

P1433

Q34717418-67340382-FAC2-4E49-A1D1-6FB9CD054F3F

P1476

Q34717418-E9787C04-C81F-430E-8493-238C2D425797

P2093

Q34717418-2657C327-5978-42F8-9355-4C79CD9084AD

Q34717418-445E447E-AE19-447A-A95B-AFBCF5FB2594

Q34717418-9EAC20B1-5CBB-4EE4-BD45-479EB6FF1F27

P2860

Q34717418-07BA14F5-6BD5-468A-8DC1-ECCA68C77F2F

Q34717418-08FF3E27-4837-4862-B076-9739F157A9A3

Q34717418-0F86CB5D-ACE4-404F-96C1-BDD5EC035F30

Q34717418-15D567A0-056A-498F-860B-A4C0BAD34424

Q34717418-18508884-4E60-4E86-BC13-D075FCEB27A8

Q34717418-21BB3D6C-036B-43FA-A950-79334C1C96F2

Q34717418-27FCB458-F7C0-4587-921A-33A2247E1427

Q34717418-2F9EB1B0-E015-4DAC-A6C3-496C2D03340D

Q34717418-30E1EA4D-CA97-472D-AE83-8A2869C045E0

Q34717418-33975E72-8138-4E50-8FF6-A2F1AB1457DC

P2888

Q34717418-8B727E3E-EFBA-44CD-8A95-46723F1DACBA

P304

Q34717418-781BD1B4-3659-4568-AD6E-65919D043A12

P31

Q34717418-5CC68686-7BFD-4468-B986-C3DA6C0890CF

P356

Q34717418-DB94BE26-0537-4AAF-BB8A-ABF0DECBF660

P407

Q34717418-2242A642-3035-4F28-8387-CDC75D2AA7C5

P433

Q34717418-7AD4AF69-F015-40AA-9C83-5DAD7D4A1F69

P478

Q34717418-DEB74D18-06BE-4BD0-9E77-9D0EFAED2F15

P50

Q34717418-068CC5F4-31DF-4F4F-B947-243E8D131857

Q34717418-62A1CD3E-22E8-44EB-AA99-2C2F2ABFB8D6

P577

Q34717418-EF584CDE-6FB9-4F43-B58E-C46F6619F304

P5875

Q34717418-168B4B8A-95DF-49E6-AB81-A231D13F7499

P6179

Q34717418-3C7D301F-0A17-4953-821E-16BC6B06233B

P698

Q34717418-A24B4CD5-B565-4399-A4A3-AF8DF7895D77

P921

Q34717418-8a24ba86-29f6-4fbb-9852-0b806fca57d3

Q34717418-B4936E2E-1922-4371-BEE1-EF96CF388B30

P356

P1433

Neuropsychopharmacology

P1476

Alpha6-containing nicotinic ac ...... nsmission in nucleus accumbens

@en

P2093

J Michael McIntosh

http://www.w3.org/2001/XMLSchema#string

Michael A Clements

http://www.w3.org/2001/XMLSchema#string

Richard Exley

http://www.w3.org/2001/XMLSchema#string

P2860

A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors

Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine

Dopamine, learning and motivation

Getting formal with dopamine and reward

Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum.

Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems.

Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes.

Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons.

Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain.

Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy.

P2888

P304

2158-2166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.NPP.1301617

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Stephanie J Cragg

Henrike Hartung

P577

2007-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5814762

http://www.w3.org/2001/XMLSchema#string

P6179

1053664732

http://www.w3.org/2001/XMLSchema#string

P698

18033235

http://www.w3.org/2001/XMLSchema#string

P921

nucleus accumbens